Praxis Precision Medicines, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the 2021 Annual Meeting of Stockholders held by Praxis Precision Medicines, Inc. on June 8, 2021. The company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol PRAX. The filing reports the final voting results for matters submitted to security holders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes rather than financial performance.
Material Changes
No material financial changes are reported in this document. The primary event is the completion of the annual stockholder vote, resulting in the election of a new director and the ratification of the independent auditor.
Outlook, Risks, and Management Commentary
Management commentary is limited to the reporting of voting results. No specific guidance, outlook, risks, or contingencies are detailed in this filing. The company confirmed that no other matters were submitted to or voted on by stockholders at the meeting.
Key Facts for Investors
- Director Election: Stockholders elected Dean Mitchell as a Class I Director for a three-year term ending in 2024.
- Voting Results (Proposal 1): Dean Mitchell received 19,795,034 votes for, 1,789,406 votes withheld, and 1,836,960 broker non-votes.
- Auditor Ratification: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021.
- Voting Results (Proposal 2): The proposal received 23,420,511 votes for, 889 votes against, and 0 abstentions.
- Quorum: A quorum was present at the Annual Meeting.